No connection

Search Results

Corporate Score 78 Bullish

Gilead acquires first TCE asset with $2.2bn Ouro Medicines buyout

Mar 24, 2026 17:32 UTC
GILD, XLV, IHF
Short term

Gilead acquires first TCE asset with $2.2bn Ouro Medicines buyout.

Share this article

Related Articles

Stay Ahead of the Markets

Join thousands of traders using AI-powered market intelligence. Get personalized insights, real-time alerts, and advanced analysis tools.

Home
Terminal
AI
Markets
Profile